MSA Safety vs Oruka Therapeutics
MSA Safety (MSA), health care, and Oruka Therapeutics (ORKA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
MSA Safety and Oruka Therapeutics are valued at about the same: $6.7B and $6.5B. Over the past year MSA Safety's share price has moved +8.64% and Oruka Therapeutics's +262%.
Key facts
- MSA Safety market value
- $6.7B
- Oruka Therapeutics market value
- $6.5B
- MSA Safety P/E
- 22.2
- MSA Safety revenue
- $1.9BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | MSA Safety | Oruka Therapeutics |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $6.7Bhigher | $6.5Blower |
| Revenue | $1.9B | — |
| Earnings | $278.9Mhigher | -$105.4Mlower |
| Employees | 5,300higher | 68lower |
| Total assets | $2.6Bhigher | $488.6Mlower |
| Valuation | ||
| P/E | 22.2 | — |
| P/S | 3.6 | — |
| P/B | 4.7lower | 5.4higher |
| Dividend yield | 1.26%higher | 0.00%lower |
| Profitability | ||
| Operating margin | 19.8% | — |
| Balance sheet | ||
| Net assets | $1.4Bhigher | $471.9Mlower |
| Total liabilities | $1.2Bhigher | $16.7Mlower |
| Total debt | $580.9M | — |
| Cash on hand | $165.1Mhigher | $46.9Mlower |
| Price change | ||
| Today | +1.38%higher | -2.94%lower |
| 1 year | +8.64%lower | +262%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
MSA Safety only (4)
- Sequoia Fund team4.9%
- François Rochon2.0%
- Pat English1.9%
- Chuck Royce (founder)0.6%
Oruka Therapeutics only (3)
- Peter Kolchinsky1.3%
- Andreas Halvorsen0.4%
- Polen Capital team<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns MSA · Who owns ORKA
More on MSA Safety
Further comparisons
MSA Safety against its closest peers
Oruka Therapeutics against its closest peers
Learn
Questions and answers
Which is bigger, MSA Safety or Oruka Therapeutics?
By market value, MSA Safety is the larger: $6.7B against $6.5B for Oruka Therapeutics.
Which has the higher dividend yield?
MSA Safety: 1.26%, against 0.00% for Oruka Therapeutics. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both MSA Safety and Oruka Therapeutics?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold MSA Safety and 3 hold Oruka Therapeutics.
Cite this page
Funkfolio, “MSA Safety vs Oruka Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/msa-vs-orka
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.